Article Sidebar
Views PDF: 132
Báo cáo ca lâm sàng : Phối hợp chẹn bóng động mạch chậu trong và nút động mạch tử cung dự phòng xuất huyết ở sản phụ mắc rau cài răng lược kết hợp rau tiền đạo
Main Article Content
Abstract
Placenta acrreta spectrum is a condition in which the placenta partially or completely invades and cannot be separated from the uterus muscle. Placenta previa is a condition in which the placenta partially or completely covers the cervix. Both phenomena increase the risk of postpartum haemorrhage, hemostasis disorders, and threaten the life of the mother and the fetus. Combine of the two phenomena increase blood loss in cesarean delivery as well as postpartum period, and is a great challenge required multidisciplinary for successful management. Prophylactic endovascular intervention is a minimally invasive treatment method, which plays an important role in prevent haemorrhage in the management of placenta accreta spectrum. This report describes a case of placenta percreta combine with placenta previa, which received prophylactic endovascular intervention using balloon occlusion of internal illiacs and uterine arteries embolization and underwent a cesarean delivery at 36 weeks. The patient had a successful delivery and preserved the uterus after surgery.
Article Details
Keywords
Placenta acrreta spectrum, prophylatic balloon occlusion, uterine artery embolization
References
2. He W, Jin Y, Zhou X, et al. Alveolar rhabdomyosarcoma of the vulva in an adult: a case report and literature review. J Int Med Res. 2020 Mar;48(3):300060520905438. doi: 10.1177/0300060520905438.PMID: 32223663
3. Tordecilla C J, Mosso Ch C, Franco S C, et al. Primary alveolar rhabdomyosarcoma of bone. Andes Pediatr. 2021 Jun;92(3):440-445. doi: 10.32641/andespediatr.v92i3.2613.PMID: 34479252
4. Dziuba I, Kurzawa P, Dopierała M, et al. Rhabdomyosarcoma in children - current pathologic and molecular classification. Pol J Pathol. 2018;69(1):20-32. doi: 10.5114/pjp.2018.75333.PMID: 29895123
5. Kumar A, Pothula V. Parameningeal alveolar rhabdomyosarcoma in a child.
BMJ Case Rep. 2021 Jul 15;14(7):e243267. doi: 10.1136/bcr-2021-243267.PMID: 34266827
6. Vanella DS, Marengo A, Blando J, Villa A. Alveolar rhabdomyosarcoma with cardiac metastasis in a pediatric patient. Arch Argent Pediatr. 2021 Aug;119(4):e349-e352. doi: 10.5546/aap.2021.e349.PMID: 34309316
7. Lu H, Qin J, Wang Z. Pleural Alveolar Rhabdomyosarcoma.
Clin Lab. 2017 Oct 1;63(10):1745-1748. doi: 10.7754/Clin.Lab.2017.170529.PMID: 29035460
8. Motoda N, Nakamura Y, Kuroki M, et al. Exfoliation of Alveolar Rhabdomyosarcoma Cells in the Ascites of a 50-Year-Old Woman: Diagnostic Challenges and Literature Review. J Nippon Med Sch. 2019 Sep 3;86(4):236-241. doi: 10.1272/jnms.JNMS.2018_86-404. Epub 2019 Apr 26.PMID: 31061253
9. Straccia P, Martini M, Pierconti F. Pericardial metastasis from alveolar rhabdomyosarcoma: A case report.
Diagn Cytopathol. 2021 Aug;49(8):E297-E300. doi: 10.1002/dc.24717. Epub 2021 Feb 9.PMID: 33560576
10. Taseer R, Ahmed TT. Embryonal Rhabdomyosarcoma Presenting as Lung Metastasis in an Adult: An Uncommon Presentation.
Cureus. 2021 Feb 24;13(2):e13545. doi: 10.7759/cureus.13545.PMID: 33786248
11. Noda T, Todani T, Watanabe Y, Uemura S, Urushihara N, Morotomi Y, Sasaki K. Alveolar rhabdomyosarcoma of the lung in a child.
J Pediatr Surg. 1995 Nov;30(11):1607-8. doi: 10.1016/0022-3468(95)90169-8.PMID: 8583337
12. Kebudi R, Ayan I, Görgün O, et al. Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol. 2005 Jan;71(1):43-8. doi: 10.1007/s11060-004-4840-y.PMID: 15719274
13. Dong Y, Zhang X, Wang S, et al. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma. Nucl Med Mol Imaging. 2017 Dec;61(4):438-446. doi: 10.23736/S1824-4785.17.02792-3. Epub 2015 May 21.PMID: 25996974
14. Ricard F, Cimarelli S, Deshayes E, et al. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med. 2011 Aug;36(8):672-7. doi: 10.1097/RLU.0b013e318217ae2e.PMID: 21716019
15. Yu J, Liu D, Sun X, et al. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression. Cell Death Dis. 2019 Jan 10;10(1):26. doi: 10.1038/s41419-018-1263-9.PMID: 30631044
16. Polivanova TV, Kasparov EV, Vshivkov VA, et al. Biomarkers CDX2, CK20, CK7 in Schoolchildren with Gastritis in the Realization of Familial Predisposition of Stomach Cancer. Bull Exp Biol Med. 2021 Dec;172(2):187-190. doi: 10.1007/s10517-021-05360-8. Epub 2021 Dec 2.PMID: 34853972
17. Veena VS, Saritha VN, George PS, et al. Immunoexpression of TTF1 and p63. Differentiates Lung Adenocarcinomas in Sputum Samples. J Cytol. 2021 Jul-Sep;38(3):151-157. doi: 10.4103/JOC.JOC_252_16. Epub 2021 Aug 23.PMID: 34703092